Information:
Fel:
ID
16301
Beskrivning
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193180
Länk
https://clinicaltrials.gov/show/NCT00193180
Nyckelord
Versioner (1)
- 2016-07-10 2016-07-10 -
Uppladdad den
10 juli 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT00193180
Eligibility Breast Cancer NCT00193180
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00193180
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Inclusion Criteria
Item
to be included in this study, you must meet the following criteria:
boolean
C1512693 (UMLS CUI [1])
metastatic breast cancer
Item
metastatic breast cancer confirmed by biopsy
boolean
C0278488 (UMLS CUI [1])
prior chemotherapy regimen for metastatic breast cancer
Item
no more than one prior chemotherapy regimen for metastatic breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,2])
ability to perform activities of daily living
Item
able to perform activities of daily living with minimal assistance
boolean
C1518965 (UMLS CUI [1])
adequate bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
Written Informed Consent
Item
give written informed consent
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
C0680251 (UMLS CUI [1])
moderate to severe peripheral neuropathy
Item
moderate to severe peripheral neuropathy
boolean
C0031117 (UMLS CUI [1,1])
C0439793 (UMLS CUI [1,2])
C0439793 (UMLS CUI [1,2])
uncontrolled blood pressure or uncontrolled heart beat irregularities
Item
uncontrolled blood pressure or uncontrolled heart beat irregularities
boolean
C0005823 (UMLS CUI [1])
C0003811 (UMLS CUI [2])
C0003811 (UMLS CUI [2])
diabetes mellitus with fasting blood sugar greater than 200 mg %
Item
diabetes mellitus with fasting blood sugar greater than 200 mg %
boolean
C0011849 (UMLS CUI [1,1])
C2825162 (UMLS CUI [1,2])
C2825162 (UMLS CUI [1,2])
Heart disease
Item
significant heart disease within the prior 6 months
boolean
C0018799 (UMLS CUI [1])
severe or uncontrolled medical disease
Item
severe or uncontrolled medical disease
boolean
C0009488 (UMLS CUI [1])
Infection
Item
active uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
chronic liver disease
Item
known chronic liver disease
boolean
C0341439 (UMLS CUI [1])
HIV Infection
Item
known diagnosis of hiv infection
boolean
C0019693 (UMLS CUI [1])
pregnant or breast feeding
Item
pregnant or breast feeding females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Additional Criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1516637 (UMLS CUI [1])